NAALADase inhibition reduces alcohol consumption in the alcohol-preferring (P) line of rats

Addiction Biology

Volumn 5, Issue 4, 2000, Pages 411-416

  McKinzie, D L ^a,e   Li, T K ^b   McBride, W J ^a   Slusher, B S ^c,d  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c Department of Research   (United States)

^d GUILFORD PHARMACEUTICALS INC   (United States)

^e ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (PHOSPHONOMETHYL)PENTANEDIOIC ACID; ALCOHOL; BRAIN PEPTIDE; ENZYME INHIBITOR; GAMMA GLUTAMYL HYDROLASE; GLUTAMATE CARBOXYPEPTIDASE II; GLUTAMIC ACID; GLUTARIC ACID DERIVATIVE; N ACETYLASPARTIC ACID; N ACETYLASPARTYLGLUTAMIC ACID; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; FEMALE; FLUID INTAKE; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

EID: 0033766443     PISSN: 13556215     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2000.tb00209.x     Document Type: Article

References (57)

1. Alcohol self-infusion into the ventral tegmental area by alcohol-preferring rats
2. Genetic influences on alcohol preference in animals
3. Intragastric self-infusion of alcohol by the P and the NP (alcohol-preferring and -non-preferring) lines of rats
4. Chronic ethanol upregulates NMDA and AMPA, but not kainate receptor subunit proteins in rat primary cortical cultures
5. Chronic ethanol treatment produces a selective upregulation of the NMDA receptor subunit gene expression in mammalian cultured cortical neurons
6. Chronic ethanol treatment upregulates the NMDA receptor function and binding in mammalian cortical neurons
7. Ethanol inhibits NMDA-activated ion currents in hippocampal neurons
8. NMDA receptor-mediated synaptic excitation selectively inhibited by ethanol in hippocampal slice from adult rat
9. Repeated ethanol withdrawal experience selectively alters sensitivity to different chemoconvulsant drugs in mice
10. Chronic ethanol exposure and withdrawal influence NMDA receptor subunit and splice variant mRNA expression in the rat cerebral cortex
11. Increased glutamatergic neurotransmission and oxidative stress after alcohol withdrawal
12. Anti-craving compounds for ethanol: New pharmacological tools to study addictive processes
13. Relapse prevention by acamprosate: Results from a placebo controlled study in alcohol dependence
14. The nagging question of the function of N-acetylaspartylglutamate
15. N-Acetylaspartyl-glutamate: Recent developments
16. Selective release of N-acetylaspartylglutamate from rat optic nerve terminals in vivo
17. NAAG selectively activates mGluR3 receptors in transfected cells
18. 3H]norepinephrine release from rat hippocampal slices
19. Low concentration N-acetylaspartylglutamate suppresses the climbing fiber response of Purkinje cells in Guinea pig cerebellar slices and the responses to excitatory amino acids of Xenopus laevis oocytes injected with cerebellar mRNA
20. High concentrations of N-acetylaspartylglutamate and AMPA, kinate, and NMDA binding sites
21. Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate. Identification and characterization of a novel N-acetylated alpha-linked acidic dipeptidase activity from rat brain
22. Rat brain N-acetylated alpha-linked acidic dipeptidase activity. Purification and immunologic characterization
23. The effects of N-acetylated alpha-linked acidic dipeptidases (NAALDase) inhibitors on [3H]NAAG catabolism in vivo
24. The regional distribution of N-acetylaspartylglutamate(NAAG) and peptidase activity against NAAG in the rat nervous system
25. Genetically epilepsy-prone rats have increased brain regional activity of an enzyme which liberates glutamate from N-acetylaspartylglutamate
26. Glutamate receptors in alcohol withdrawal-induced neurotoxicity
27. Protection against ischaemic neuronal damage by drugs acting on excitatory neurotransmission
28. Glutamate and the pathophysiology of hypoxic-ischemic brain death
29. Mechanism of action of acamprosate. Part II. Ethanol dependence modifies effects of acamprosate on NMDA receptor binding in membranes from rat cerebral cortex
30. The role of glutamatergic neurotransmission in the pathophysiology of alcoholism
31. Central effects of acamprosate: Part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats
32. Acamprosate in alcohol dependence: How does it work?
33. Design, synthesis, and biological activity of a potent inhibitor of the neuropeptidase N-acetylated-alpha-linked acidic dipeptidase
34. Ethanol effects on central N-methyl-D-aspartate receptors
35. Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats
36. Time course of acamprosate action on operant ethanol self-administration after ethanol deprivation
37. Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat
38. NAALADase inhibition attenuates the development of behavioral sensitization to cocaine
39. Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain iniury
40. Neurocircuitry targets in ethanol reward and dependence
41. Neurotransmitter and neuromodulatory mechanisms involved in alcohol abuse and alcoholism
42. The glutamatergic basis of human alcoholism
43. Ethanol potentiates and blocks NMDA-activated single-channel currents in rat hippocampal pyramidal cells
44. The NMDA receptor antagonist dizocilpine differentially affects environment-dependent and environment-independent ethanol tolerance
45. Effect of (+)MK-801 and ketamine on rapid tolerance to ethanol
46. Ethanol withdrawal seizures and the NMDA receptor complex
47. The competitive NMDA receptor antagonist, CGP 39551, inhibits ethanol withdrawal seizures
48. MK-801 potently inhibits alcohol withdrawal seizures in rats
49. Pharmacotherapies for alcohol problems: A review of research with focus on developments since 1991
50. Acamprosate enhances N-methyl-D-aspartate receptor-mediated neurotransmission but inhibits presynaptic GABA(B) receptors in nucleus accumbens neurons
51. Acamprosate (calcium acetylhomotaurinate) enhances the N-methyl-D-aspartate component of excitatory neurotransmission in rat hippocampal CA1 neurons in vitro
52. Mechanism of action of acamprosate. Part 1. Characterization of spermidine-sensitive acamprosate binding sites in rat brain
53. A homotaurine derivative reduces the voluntary intake of ethanol by rats: Are cerebral GABA receptors involved?
54. Dose-dependent suppression of the high alcohol intake of chronically intoxicated rats by Ca-acetyl homotaurinate
55. GABA and nucleus accumbens glutamate neurotransmission modulate ethanol self-administration in rats
56. Comparison of acamprosate and placebo in long-term treatment of alcohol dependence
57. Acamprosate: A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification